Hideto Kameda

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

Yoshiya Tanaka, Tsutomu Takeuchi, Tsuneyo Mimori et al. · Annals of the Rheumatic Diseases · 2010 · 278 citations · Full text

Consensus statement for the diagnosis and treatment of drug-induced lung injuries

Keishi Kubo, Arata Azuma, Minoru Kanazawa et al. · Respiratory Investigation · 2013 · 272 citations · Full text

Acute Lung Injury, Pulmonary Care, Inflammatory Lung Disease +21

Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.

Hideto Kameda, Hayato Nagasawa, Hiroe Ogawa et al. · PubMed · 2005 · 230 citations

High Dose Psl, Immunosuppressive Therapy, Immunology +11

Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

Yuko Kaneko, Hideto Kameda, Kei Ikeda et al. · Annals of the Rheumatic Diseases · 2018 · 182 citations · Full text

Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

Yukiko Komano, Michi Tanaka, Toshihiro Nanki et al. · The Journal of Rheumatology · 2011 · 157 citations · Full text